Alcohol-induced hypertension: An important healthcare target in Belgium

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine

Volumn 70, Issue 6, 2015, Pages 389-395

  Collart, F ^a   De Timary, P ^b   Dom, G ^c   Dor, B D ^d   Duprez, D ^e   Lengele, J P ^b   Matthys, F ^f   Peuskens, H ^g   Rehm, J ^h   Starkel P ^b  

^a Department of Nephrology   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d Centre Hospitalier Spacialisa l'Accueil   (Belgium)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Alcohol screening; Alcohol use disorder; Harmful alcohol use; Hypertension; Primary care

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; ARTICLE; BELGIUM; CARDIOVASCULAR DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; HYPERTENSION; NEOPLASM; RISK FACTOR; SCREENING; SYSTOLIC BLOOD PRESSURE; ADVERSE EFFECTS; CHEMICALLY INDUCED; DRINKING BEHAVIOR; EPIDEMIOLOGY; PUBLIC HEALTH;

ALCOHOL DRINKING; BELGIUM; HUMANS; HYPERTENSION; PUBLIC HEALTH; RISK FACTORS;

EID: 84955444322     PISSN: 00015512     EISSN: 22953337     Source Type: Journal    
DOI: 10.1179/2295333715Y.0000000039     Document Type: Article

References (50)

1. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases, 2013-2020. Geneva, Switzerland: WHO; 2013.
2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and causespecific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-71.
3. World Health Organization. Global status report on alcohol and health. Geneva: WHO; 2014.
4. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lonnroth K, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:450.
5. Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105(5):817-43.
6. Matsumoto C, Miedema MD, Ofman P, Gaziano JM, Sesso HD. An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease. J Cardiopulm Rehabil Prev. 2014;34(3):159-71.
7. Nichols M, Scarborough P, Allender S, Rayner M. What is the optimal level of population alcohol consumption for chronic disease prevention in England? Modelling the impact of changes in average consumption levels. BMJ Open. 2012;2(3):e000957.
8. Rehm J, Lachenmeier DW, Room R. Why does society accept a higher risk for alcohol than for other voluntary or involuntary risks? BMC Med. 2014;12:189.
9. Shield KD, Parry C, Rehm J. Chronic diseases and conditions related to alcohol use. Alcohol Res. 2013;35(2):155-73.
10. Rehm J, Sempos CT, Trevisan M. Alcohol and cardiovascular disease-more than one paradox to consider. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease-A review. J Cardiovasc Risk. 2003;10(1):15-20.
11. Klatsky AL, Friedman GD, Armstrong MA, Kipp H. Wine, liquor, beer, and mortality. Am J Epidemiol. 2003;158(6):585-95.
12. Rimm EB, Klatsky A, Grobbee D, Stampfer MJ. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ. 1996;312(7033):731-6.
13. Molina PE, Gardner JD, Souza-Smith FM, Whitaker AM. Alcohol abuse: critical pathophysiological processes and contribution to disease burden. Physiology. 2014;29(3):203-15.
14. Dugernier T, Starkel P, Laterre PF, Reynaert MS. Severe acute pancreatitis: pathophysiologic mechanisms underlying pancreatic necrosis and remote organ damage. Acta Gastroenterol Belg. 1996;59(3):178-85.
15. World Health Organization. A global brief on hypertension. Why hypertension is a major public health issue. Geneva: WHO; 2013.
16. Briasoulis A, Agarwal V, Messerli FH. Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-Analysis. J Clin Hypertens (Greenwich). 2012;14(11):792-8.
17. Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in doseresponse relationships determined through systematic review and meta-Analysis. Addiction. 2009;104(12):1981-90.
18. Malhotra H, Mehta SR, Mathur D, Khandelwal PD. Pressor effects of alcohol in normotensive and hypertensive subjects. Lancet. 1985;2(8455):584-6.
19. Puddey IB, Beilin LJ, Vandongen R. Regular alcohol use raises blood pressure in treated hypertensive subjects. A randomised controlled trial. Lancet. 1987;1(8534):647-51.
20. Rosito GA, Fuchs FD, Duncan BB. Dose-dependent biphasic effect of ethanol on 24-h blood pressure in normotensive subjects. Am J Hypertens. 1999;12(2 Pt 1):236-40.
21. Stranges S, Wu T, Dorn JM, Freudenheim JL, Muti P, Farinaro E, et al. Relationship of alcohol drinking pattern to risk of hypertension: a population-based study. Hypertension. 2004;44(6):813-9.
22. Duprez D, Van HP, Van den Eynde W, Leeman M. Prevalence of hypertension in the adult population of Belgium: report of a worksite study, attention hypertension. J Hum Hypertens. 2002;16(1):47-52.
23. De Bacquer D, De Backer G. The prevalence of concomitant hypertension and hypercholesterolaemia in the general population. Int J Cardiol. 2006;110(2):217-23.
24. Banegas JR, Lopez-Garcia E, Dallongeville J, Guallar E, Halcox JP, Borghi C, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011;32(17):2143-52.
25. Van der Niepen P, Van de Borne P, Persu A, Andries A. Prevalence of hypertension and cardiovascular risk factors in Belgian civil employees: results of the screening during World Hypertension Day 2007. J Hypertens. 2008;26(5):1045-6.
26. Rehm J, Gmel G, Kiefer F, Kreutz R, Kugler J, Muller-Walther M, et al. [Improvement of management of hypertension by implementation of alcohol screening and subsequent interventions in primary practice]. Dtsch Med Wochenschr. 2014;139(48):2457-62.
27. Ueshima H, Mikawa K, Baba S, Sasaki S, Ozawa H, Tsushima M, et al. Effect of reduced alcohol consumption on blood pressure in untreated hypertensive men. Hypertension. 1993;21(2):248-52.
28. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-Analysis of randomized controlled trials. Hypertension. 2001;38(5):1112-7.
29. Okubo Y, Suwazono Y, Kobayashi E, Nogawa K. Alcohol consumption and blood pressure change: 5-year follow-up study of the association in normotensive workers. J Hum Hypertens. 2001;15(6):367-72.
30. Stamler R. Implications of the INTERSALT study. Hypertension. 1991;17(1 Suppl):I16-I20.
31. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288(15):1882-8
32. ESH/ESC Task Force for the Management of Arterial Hypertension. Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-38
33. Institut National d'Assurance Maladie Invalidité/Rijksinstituut Voor Ziekte-en Invaliditeitsverzekering. Traitement Efficient de l'Hypertension Compliquée. J. De Cock, RIZIV, Brussels, Belgium 2004.
34. Reinert DF, Allen JP. The alcohol use disorders identification test (AUDIT): a review of recent research. Alcohol Clin Exp Res. 2002;26(2):272-9.
35. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA, The AUDIT. alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789-95.
36. Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, brief intervention, and referral to treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007;28(3):7-30.
37. Kohler S, Hofmann A. Can motivational interviewing in emergency care reduce alcohol consumption in young people? A systematic review and meta-Analysis. Alcohol Alcohol. 2015;50(2):107-17.
38. Klimas J, Tobin H, Field CA, O'Gorman CS, Glynn LG, Keenan E, et al. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users. Cochrane Database Syst Rev. 2014;12:CD009269.
39. Dor B. Opportunities and challenges of alcohol screening and intervention in hypertensive patients from a primary care perspective. Screening and intervention for harmful alcohol use as a tool to improve the management of hypertension in primary care, Expert Roundtable Meeting, Brussels, Belgium ed, 2014.
40. Kaner EF, Beyer F, Dickinson HO, Pienaar E, Campbell F, Schlesinger C, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;2:CD004148.
41. O'Donnell A, Anderson P, Newbury-Birch D, Schulte B, Schmidt C, Reimer J, et al. The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcohol. 2014;49(1):66-78.
42. Ornstein SM, Miller PM, Wessell AM, Jenkins RG, Nemeth LS, Nietert PJ. Integration and sustainability of alcohol screening, brief intervention, and pharmacotherapy in primary care settings. J Stud Alcohol Drugs. 2013;74(4):598-604.
43. Heather N. The efficacy-effectiveness distinction in trials of alcohol brief intervention. Addict Sci Clin Pract. 2014;9:13.
44. Bruffaerts R, Bonnewyn A, Demyttenaere K. Troubles psychiques en Belgique au debut du XXI siecle. Etat des lieux et reflexions pour lavenir: état des lieux et réflections pour l'avenir. Acco ed. Blijde Inkomststraat, Leuven, Belgium. 2012.
45. Stein DJ, Aguilar-Gaxiola S, Alonso J, Bruffaerts R, de JP, Liu Z, et al. Associations between mental disorders and subsequent onset of hypertension. Gen Hosp Psychiatry. 2014;36(2):142-9.
46. Hermans MH, De WN, Dom G. The state of psychiatry in Belgium. Int Rev Psychiatry. 2012;24(4):286-94.
47. Drummond C, Wolstenholme A, DeLuca P, Davey Z, Donoghue K, Elzerbi C. Alcohol interventions and treatments in Europe. In: Alcohol Policy in Europe: Evidence from Amphora. Anderson P, Braddick F, Reynolds J, Gual A, editors. 2nd. Barcelona: Amphora; 2013; p. 65-80.
48. ODHIN. Optimizing delivery of health care interventions: survey of attitudes and managing alcohol problems in general practice in Europe-final REPORT. Available from: http://www.odhinproject.eu 2015.
49. Roerecke M, Rehm J. Alcohol intake revisited: risks and benefits. Curr Atheroscler Rep. 2012;14(6):556-62.
50. Singh JK, Ranjan P, Kumari A, Dahale AS, Jha R, Das R. Types, outcome and risk factors of stroke in tribal patients. Int J Stroke. 2013;8(8):675-80.